Follow
Long Luu
Title
Cited by
Cited by
Year
Rationally designed small molecules that target both the DNA and RNA causing myotonic dystrophy type 1
L Nguyen, LM Luu, S Peng, JF Serrano, HYE Chan, SC Zimmerman
Journal of the American Chemical Society 137 (44), 14180-14189, 2015
1252015
Targeting toxic RNAs that cause myotonic dystrophy type 1 (DM1) with a bisamidinium inhibitor
CH Wong, L Nguyen, J Peh, LM Luu, JS Sanchez, SL Richardson, ...
Journal of the American Chemical Society 136 (17), 6355-6361, 2014
1152014
Developing bivalent ligands to target CUG triplet repeats, the causative agent of myotonic dystrophy type 1
AH Jahromi, Y Fu, KA Miller, L Nguyen, LM Luu, AM Baranger, ...
Journal of medicinal chemistry 56 (23), 9471-9481, 2013
632013
A Potent Inhibitor of Protein Sequestration by Expanded Triplet (CUG) Repeats that Shows Phenotypic Improvements in a Drosophila Model of Myotonic Dystrophy
LM Luu, L Nguyen, S Peng, JY Lee, HY Lee, CH Wong, PJ Hergenrother, ...
ChemMedChem 11 (13), 1428-1435, 2016
492016
Intrinsically cell-penetrating multivalent and multitargeting ligands for myotonic dystrophy type 1
JY Lee, Y Bai, UV Chembazhi, S Peng, K Yum, LM Luu, LD Hagler, ...
Proceedings of the National Academy of Sciences 116 (18), 8709-8714, 2019
482019
Expanded DNA and RNA trinucleotide repeats in myotonic dystrophy type 1 select their own multitarget, sequence-selective inhibitors
LD Hagler, LM Luu, M Tonelli, JY Lee, SM Hayes, SE Bonson, JI Vergara, ...
Biochemistry 59 (37), 3463-3472, 2020
112020
Leveraging intracellular ALDH1A1 activity for selective cancer stem-like cell labeling and targeted treatment via in vivo click reaction
Y Bo, J Zhou, K Cai, Y Wang, Y Feng, W Li, Y Jiang, SH Kuo, J Roy, ...
Proceedings of the National Academy of Sciences 120 (36), e2302342120, 2023
92023
Versatile target-guided screen for discovering bidirectional transcription inhibitors of a trinucleotide repeat disease
LD Hagler, SB Krueger, LM Luu, AN Lanzendorf, NL Mitchell, JI Vergara, ...
ACS Medicinal Chemistry Letters 12 (6), 935-940, 2021
82021
E.; Baranger, AM; Hergenrother, PJ; Zimmerman, SC Targeting Toxic RNAs that Cause Myotonic Dystrophy Type 1 (DM1) with a Bisamidinium Inhibitor
CH Wong, L Nguyen, J Peh, LM Luu, JS Sanchez, SL Richardson, ...
J. Am. Chem. Soc 136 (17), 6355-6361, 2014
82014
Bisamidinium-based inhibitors for the treatment of myotonic dystrophy
SC Zimmerman, LM Luu, LTT Nguyen
US Patent 10,266,520, 2019
22019
Compounds and methods for myotonic dystrophy therapy
SC Zimmerman, LM Luu, LTT Nguyen
US Patent 9,376,421, 2016
12016
Template-assisted click chemistry as a therapuetic strategy for myotonic dystrophy type 1 (DM1)
L Hagler, L Luu, S Zimmerman
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 258, 2019
2019
Approaches to the assembly of potent therapeutic agents for the treatment of myotonic dystrophy
LM Luu
University of Illinois at Urbana-Champaign, 2016
2016
DNA and RNA in multi-target drug design for the microsatellite disease myotonic dystrophy
S Zimmerman, L Luu, L Nguyen, J Serrano, J Lee
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 251, 2016
2016
On-target synthesis and selection of modular therapeutic agents for myotonic dystrophy
L Luu
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 251, 2016
2016
Discovery of bis-amidinium ligands as potential lead agents for myotonic dystrophy type 1
LM Luu, L Nguyen, SC Zimmerman
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 248, 2014
2014
Developing bivalent ligands to target CUG triplet repeats, the causative agent of myotonic dystrophy type 1
KA Miller, AH Jahromi, L Nguyen, L Luu, SC Zimmerman
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 247, 2014
2014
Leveraging intracellular ALDH1A1 activity for selective cancer stem-like cell labeling and targeted treatment via in vivo click reaction
The Bivalent Ligand Approach Leads to a Bioactive Inhibitor of MBNL1· CUG exp Complex
AH Jahromi, Y Fu, KA Miller, L Nguyen, LM Luu, AM Baranger, ...
The system can't perform the operation now. Try again later.
Articles 1–19